1)Darling RC, Welch CE. Tumors of the small intestine. N Engl J Med 260:397-408, 1959
2)藤澤貴史,友藤喜信,黒田信稔,他.腺管絨毛腺腫を伴う早期十二指腸癌の1例—本邦報告例249例の臨床病理学的検討.Gastroenterol Endosc 37:2768-2775, 1995
3)長谷康二,竹腰隆男,馬場保昌,他.早期十二指腸癌の実態と内視鏡的治療の適応の検討—文献報告例の分析を基に.消内視鏡 5:969-976, 1993
4)Struck A, Howard T, Chiorean EG, et al. Non-ampullary duodenal adenocarcinoma:factors important for relapse and survival. J Surg Oncol 100:144-148, 2009
5)Sakamoto T, Saiura A, Ono Y, et al. Optimal Lymphadenectomy for duodenal adenocarcinoma:does the number alone matter? Ann Surg Oncol 24:3368-3375, 2017
6)吉水祥一,河内洋,山本頼正,他.非乳頭部十二指腸SM癌の12例.胃と腸 54:1131-1140, 2019
7)Yoshimizu S, Kawachi H, Yamamoto Y, et al. Clinicopathological features and risk factors for lymph node metastasis in early-stage non-ampullary duodenal adenocarcinoma. J Gastroenterol 55:754-762, 2020
8)阿部展次,吉本恵理,小島洋平,他.原発性十二指腸進行癌に対する外科治療.消内視鏡 27:1125-1131, 2015
9)Bosman FT, Carneiro F, Hruban RH(eds). WHO Classification of Tumours of the Digestive System, 4th ed. IARC, Lyon, 2010
10)八尾隆史,椛島章,上月俊夫,他.胃型分化型腺癌—新しい抗体を用いた免疫染色による癌の形質判定.胃と腸 34:477-485, 1999
11)Brierley JD, Gospodarowicz MK, Wittekind C(eds). TNM Classification of Malignant Tumours, 8th edition. Wiley-Blackwell, Hoboken, 2017
12)日本胃癌学会(編).胃癌取扱い規約,第15版.金原出版, 2017
13)Association JGC. Japanese gastric cancer treatment guidelines 2010. Gastric Cancer 14:113-123, 2011
14)Watanabe T, Muro K, Ajioka Y, et al. Japanese Society for Cancer of the Colon and Rectum(JSCCR)guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol 23:1-34, 2018
15)Sekiguchi M, Oda I, Taniguchi H, et al. Risk stratification and predictive risk-scoring model for lymph node metastasis in early gastric cancer. J Gastroenterol 51:961-970, 2016
16)浦岡俊夫,栗林志行,田中寛人,他.表在性十二指腸癌におけるSM癌頻度とリンパ節転移率.消内視鏡 31:1002-1006, 2019
17)Sarela AI, Brennan MF, Karpeh MS, et al. Adenocarcinoma of the duodenum:importance of accurate lymph node staging and similarity in outcome to gastric cancer. Ann Surg Oncol 11:380-386, 2004
18)Kakushima N, Ono H, Takao T, et al. Method and timing of resection of superficial non-ampullary duodenal epithelial tumors. Dig Endosc 26(Suppl 2):35-40, 2014
19)Poultsides GA, Huang LC, Cameron JL, et al. Duodenal adenocarcinoma:clinicopathologic analysis and implications for treatment. Ann Surg Oncol 19:1928-1935, 2012
20)Kato Y, Takahashi S, Kinoshita T, et al. Surgical procedure depending on the depth of tumor invasion in duodenal cancer. Jpn J Clin Oncol 44:224-231, 2014
21)Hida R, Yamamoto H, Hirahashi M, et al. Duodenal neoplasms of gastric phenotype:an immunohistochemical and genetic study with a practical approach to the classification. Am J Surg Pathol 41:343-353, 2017
22)Gotoda T, Yanagisawa A, Sasako M, et al. Incidence of lymph node metastasis from early gastric cancer:estimation with a large number of cases at two large centers. Gastric Cancer 3:219-225, 2000
23)Li D, Si X, Wan T, et al. Outcomes of surgical resection for primary duodenal adenocarcinoma:A systematic review. Asian J Surg 42:46-52, 2019
24)Goda K, Kikuchi D, Yamamoto Y, et al. Endoscopic diagnosis of superficial non-ampullary duodenal epithelial tumors in Japan:Multicenter case series. Dig Endosc 26(Suppl 2):23-29, 2014
25)Ushiku T, Arnason T, Fukayama M et al. Extra-ampullary duodenal adenocarcinoma. Am J Surg Pathol 38:1484-1493, 2014
26)Toba T, Inoshita N, Kaise M, et al. Clinicopathological features of superficial non-ampurally duodenal epithelial tumor ; gastric phenotype of histology correlates to higher malignant potency. J Gastroenterol 53:64-70, 2018
27)Minatsuki C, Yamamichi N, Inada KI, et al. Expression of gastric markers is associated with malignant potential of nonampullary duodenal adenocarcinoma. Dig Dis Sci 63:2617-2625, 2018